Comparison of Oocyte and Embryo Quality Between Random Start and Controlled Ovarian Stimulation Cycles in Cancer Patients Undergoing Fertility Preservation

Guler Israfilova, Yavuz Emre Sukur, Sinan Ozkavukcu, Meltem Aksu Sonmezer, Cem Somer Atabekoglu, Batuhan Ozmen, Bulent Berker, Rusen Aytac, Acar Koc, Murat Sonmezer (Lead / Corresponding author)

Research output: Contribution to journalArticlepeer-review

Abstract

Conventional assisted reproductive technology (ART) cycles may delay cancer treatment and compromise survival, and also increase patients’ psychological burden as a result of delayed chemotherapy. The aim of this study was to compare the success rates of random start and conventional start GnRH antagonist protocols in terms of oocyte and embryo outputs in cancer patients. Data of 111 patients with a newly diagnosed cancer who underwent ART for fertility preservation at a university-based infertility clinic between January 2010 and September 2019 were reviewed. The study group underwent random start controlled ovarian hyperstimulation (RS-COH) and the control group underwent conventional start COH (CS-COH). The main outcome measures were the number of total oocytes, MII oocytes, and embryo yield. A total of 46 patients (41.5%) underwent RS-COH and 65 (58.5%) underwent CS-COH. Baseline characteristics were similar between the groups. The most common cancer type in both groups was breast cancer (60.9% vs. 52.3%, respectively). The median duration of stimulation was significantly longer in RS-COH than in CS-COH (12 vs. 10 days; P = 0.005). The median number of MII oocytes was significantly higher in RS-COH than in CS-COH (7 vs. 5 oocytes, respectively; P = 0.020). The MII/AFC ratio was significantly higher in the RS-COH group compared to the CS-COH group (74% and 57% respectively; p = 0.02). In the linear regression analyses, RS-COH protocol did not have a significant impact on MII/AFC (standardized ß coefficient − 0.514; P = 0.289 {adjusted R 2 for the model = 0.779}), oocyte yield (standardized ß coefficient − 0.070; P = 0.829 {adjusted R 2 for the model = 0.840}), and MII rate (standardized ß coefficient − 0.504; P = 0.596 {adjusted R 2 for the model = 0.271}). In conclusion, RS-COH protocol is as effective as CS-COH protocols for fertility preservation in cancer patients.

Original languageEnglish
Pages (from-to)2200-2207
Number of pages8
JournalReproductive Sciences
Volume28
Issue number8
DOIs
Publication statusPublished - 1 Aug 2021

Keywords

  • Controlled ovarian hyperstimulation
  • Cryopreservation
  • Fertility preservation
  • Oocyte yield
  • Random start

Fingerprint

Dive into the research topics of 'Comparison of Oocyte and Embryo Quality Between Random Start and Controlled Ovarian Stimulation Cycles in Cancer Patients Undergoing Fertility Preservation'. Together they form a unique fingerprint.

Cite this